FBIO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Fortress Biotech Inc (FBIO) is not a strong buy at the moment for a beginner investor with a long-term focus. The technical indicators are bearish, options data suggests weak sentiment, and financial performance shows declining profitability. While there are no significant positive catalysts or recent news, the lack of strong trading signals and negative financial trends make it prudent to hold off on investing right now.
The technical indicators for FBIO are bearish. The MACD histogram is below 0 and negatively contracting, the RSI is neutral at 32.17, and moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 2.405, with resistance at 2.557 and support at 2.252. Overall, the trend suggests weakness.
NULL identified. No significant news or events have been reported recently. Hedge funds and insiders are neutral, and there is no recent congress trading activity.
The stock has shown a regular market decline of -3.29%, and financial performance has deteriorated with declining net income (-35.79% YoY) and EPS (-45.95% YoY). Additionally, gross margin has dropped by 4.83% YoY.
In Q4 2025, revenue increased by 6.34% YoY to $16.08M, but net income dropped by 35.79% YoY to -$6.198M. EPS fell by 45.95% YoY to -0.2, and gross margin declined to 59.54%, down 4.83% YoY. The financials indicate growth in revenue but worsening profitability.
No data on recent analyst ratings or price target changes. Wall Street sentiment is unclear.
